The assets do not include NewYork-Presbyterian’s hospital-based labs. The deal is expected to be completed in the second quarter of 2023, pending regulatory approval. Terms were not disclosed.
“NewYork-Presbyterian and Quest share a belief that exceptional patient care should be accessible to all,” said NewYork-Presbyterian President and CEO Steven Corwin, MD, said in a Feb. 14 Quest news release. “We determined that working with Quest would be the best path — allowing our patients wider access to advanced, quality laboratory services.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
